Phase 2, open-label single arm study of the efficacy and safety of PF 02341066 in patients with advanced non-small cell lung cancer (NSCLC) harboring a translocation or inversion involving the anaplastic lymphoma kinase (ALK) gene locus

View Statistics Email Alert RSS Feed

Grant Data
Project Title
Phase 2, open-label single arm study of the efficacy and safety of PF 02341066 in patients with advanced non-small cell lung cancer (NSCLC) harboring a translocation or inversion involving the anaplastic lymphoma kinase (ALK) gene locus
Principal Investigator
Dr Ho, James Chung Man   (Principal Investigator (PI))
Co-Investigator(s)
Dr Lam Chung Mei Jamie   (Co-Investigator)
Dr Lam Chi Leung David   (Co-Investigator)
Dr Wong King Yan Matthew   (Co-Investigator)
Duration
41
Start Date
2010-04-07
Amount
90458
Conference Title
Phase 2, open-label single arm study of the efficacy and safety of PF 02341066 in patients with advanced non-small cell lung cancer (NSCLC) harboring a translocation or inversion involving the anaplastic lymphoma kinase (ALK) gene locus
Presentation Title
Keywords
anaplastic lymphoma kinase, non-small cell lung cancer
Discipline
Cancer,Respiration
HKU Project Code
N/A
Grant Type
Pharmaceutical Industry - General Award
Funding Year
2010
Status
On-going